Synaptics (SYNA) director granted 3,036 RSUs; vests by 2026
Synaptics (SYNA) director reported an equity grant.
Rhea-AI Filing Summary
Synaptics (SYNA) director reported an equity grant. On 11/03/2025, a director acquired 3,036 shares of common stock for $0, reflected as a restricted stock unit award. Following the transaction, the director beneficially owned 14,334 shares, held directly.
The award vests in equal quarterly installments, with one-fourth vesting each quarter until fully vested on November 3, 2026, or, for a director not standing for re‑election, on the date of the company’s 2026 Annual Meeting of Stockholders.
Positive
- None.
Negative
- None.
Insights
Routine RSU grant to a director with quarterly vesting.
The filing reports a director’s award of 3,036 restricted stock units at a stated price of $0, a common structure for board compensation. Post‑grant beneficial ownership is 14,334 shares, held directly.
Vesting occurs quarterly until fully vested by November 3, 2026, or accelerates to the date of the 2026 Annual Meeting if the director does not stand for re‑election. This is administrative in nature and does not indicate proceeds to the company.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,036 | $0.00 | $0.00 |
Footnotes (1)
- F1. One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders.
FAQ
What did Synaptics (SYNA) report in this Form 4?
What are the vesting terms for the RSUs reported by SYNA?
Were any derivative securities involved in this SYNA Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.